nodes	percent_of_prediction	percent_of_DWPC	metapath
Nortriptyline—attention deficit hyperactivity disorder—Bupropion—obesity	0.102	0.355	CpDpCtD
Nortriptyline—attention deficit hyperactivity disorder—Methamphetamine—obesity	0.102	0.355	CpDpCtD
Nortriptyline—panic disorder—Bupropion—obesity	0.0836	0.29	CpDpCtD
Nortriptyline—Cyclobenzaprine—Benzphetamine—obesity	0.0436	0.378	CrCrCtD
Nortriptyline—HTR2C—obesity	0.0409	0.221	CbGaD
Nortriptyline—Atomoxetine—Benzphetamine—obesity	0.0363	0.315	CrCrCtD
Nortriptyline—Trimipramine—Benzphetamine—obesity	0.0354	0.307	CrCrCtD
Nortriptyline—SLC6A4—obesity	0.0339	0.183	CbGaD
Nortriptyline—DRD2—obesity	0.0337	0.182	CbGaD
Nortriptyline—CYP2E1—obesity	0.0324	0.176	CbGaD
Nortriptyline—HTR2A—obesity	0.026	0.141	CbGaD
Nortriptyline—SLC6A2—Diethylpropion—obesity	0.0198	0.0731	CbGbCtD
Nortriptyline—SLC6A4—Sibutramine—obesity	0.0179	0.0662	CbGbCtD
Nortriptyline—ALB—obesity	0.0178	0.0964	CbGaD
Nortriptyline—ADRA1B—Phendimetrazine—obesity	0.0164	0.0607	CbGbCtD
Nortriptyline—SLC6A2—Sibutramine—obesity	0.015	0.0554	CbGbCtD
Nortriptyline—SLC6A2—Phendimetrazine—obesity	0.015	0.0554	CbGbCtD
Nortriptyline—ORM1—Bupropion—obesity	0.014	0.0516	CbGbCtD
Nortriptyline—SLC6A4—Phentermine—obesity	0.0136	0.0502	CbGbCtD
Nortriptyline—ADRA1A—Phendimetrazine—obesity	0.013	0.0479	CbGbCtD
Nortriptyline—SLC6A2—Benzphetamine—obesity	0.0114	0.042	CbGbCtD
Nortriptyline—SLC6A2—Phentermine—obesity	0.0114	0.042	CbGbCtD
Nortriptyline—SLC6A4—Methamphetamine—obesity	0.0109	0.0401	CbGbCtD
Nortriptyline—SLC6A2—Phenylpropanolamine—obesity	0.0109	0.04	CbGbCtD
Nortriptyline—ADRA1A—Benzphetamine—obesity	0.00983	0.0363	CbGbCtD
Nortriptyline—SLC6A2—Bupropion—obesity	0.00967	0.0357	CbGbCtD
Nortriptyline—ADRA1A—Phenylpropanolamine—obesity	0.00938	0.0346	CbGbCtD
Nortriptyline—SLC6A2—Methamphetamine—obesity	0.00909	0.0336	CbGbCtD
Nortriptyline—CYP2E1—Bupropion—obesity	0.00609	0.0225	CbGbCtD
Nortriptyline—CYP2E1—Cimetidine—obesity	0.00447	0.0165	CbGbCtD
Nortriptyline—CYP1A2—Phentermine—obesity	0.00414	0.0153	CbGbCtD
Nortriptyline—CYP1A2—Phenylpropanolamine—obesity	0.00395	0.0146	CbGbCtD
Nortriptyline—CYP2C9—Phentermine—obesity	0.00373	0.0138	CbGbCtD
Nortriptyline—CYP1A2—Bupropion—obesity	0.00352	0.013	CbGbCtD
Nortriptyline—CYP3A5—Cimetidine—obesity	0.00347	0.0128	CbGbCtD
Nortriptyline—CYP2D6—Phentermine—obesity	0.00341	0.0126	CbGbCtD
Nortriptyline—CYP2C9—Bupropion—obesity	0.00317	0.0117	CbGbCtD
Nortriptyline—CYP2D6—Bupropion—obesity	0.0029	0.0107	CbGbCtD
Nortriptyline—CYP3A4—Sibutramine—obesity	0.00286	0.0106	CbGbCtD
Nortriptyline—CYP2C19—Cimetidine—obesity	0.0028	0.0103	CbGbCtD
Nortriptyline—CYP2D6—Methamphetamine—obesity	0.00273	0.0101	CbGbCtD
Nortriptyline—CYP1A2—Cimetidine—obesity	0.00258	0.00953	CbGbCtD
Nortriptyline—CYP2C9—Cimetidine—obesity	0.00233	0.00859	CbGbCtD
Nortriptyline—CYP3A4—Benzphetamine—obesity	0.00217	0.008	CbGbCtD
Nortriptyline—CYP2D6—Cimetidine—obesity	0.00213	0.00785	CbGbCtD
Nortriptyline—CYP3A4—Bupropion—obesity	0.00184	0.0068	CbGbCtD
Nortriptyline—CYP2C19—Topiramate—obesity	0.00183	0.00676	CbGbCtD
Nortriptyline—ORM1—bile—obesity	0.00153	0.0886	CbGeAlD
Nortriptyline—CYP3A4—Orlistat—obesity	0.0015	0.00555	CbGbCtD
Nortriptyline—CHRM3—muscle of abdomen—obesity	0.0014	0.0812	CbGeAlD
Nortriptyline—CYP3A4—Cimetidine—obesity	0.00135	0.00499	CbGbCtD
Nortriptyline—SLC6A2—sympathetic nervous system—obesity	0.00114	0.066	CbGeAlD
Nortriptyline—CYP3A4—Topiramate—obesity	0.000886	0.00327	CbGbCtD
Nortriptyline—SLC6A2—autonomic nervous system—obesity	0.000764	0.0444	CbGeAlD
Nortriptyline—HTR2A—sympathetic nervous system—obesity	0.000683	0.0397	CbGeAlD
Nortriptyline—HTR2A—vagus nerve—obesity	0.000662	0.0384	CbGeAlD
Nortriptyline—HTR2A—autonomic nervous system—obesity	0.000459	0.0267	CbGeAlD
Nortriptyline—ORM1—gall bladder—obesity	0.000424	0.0246	CbGeAlD
Nortriptyline—ALB—gall bladder—obesity	0.000371	0.0216	CbGeAlD
Nortriptyline—SLC6A4—hindbrain—obesity	0.000366	0.0212	CbGeAlD
Nortriptyline—HTR1A—hindbrain—obesity	0.000325	0.0189	CbGeAlD
Nortriptyline—ADRA1A—hindbrain—obesity	0.000299	0.0174	CbGeAlD
Nortriptyline—DRD2—hindbrain—obesity	0.000293	0.017	CbGeAlD
Nortriptyline—SLC6A4—respiratory system—obesity	0.000223	0.013	CbGeAlD
Nortriptyline—SLC6A2—respiratory system—obesity	0.000197	0.0114	CbGeAlD
Nortriptyline—HTR2A—hindbrain—obesity	0.000194	0.0112	CbGeAlD
Nortriptyline—Atomoxetine—NPY1R—obesity	0.000192	0.112	CrCbGaD
Nortriptyline—CHRM2—cardiovascular system—obesity	0.000187	0.0109	CbGeAlD
Nortriptyline—DRD2—respiratory system—obesity	0.000179	0.0104	CbGeAlD
Nortriptyline—CYP2D6—hindbrain—obesity	0.000176	0.0102	CbGeAlD
Nortriptyline—CHRM1—cardiovascular system—obesity	0.00017	0.0099	CbGeAlD
Nortriptyline—ADRA1D—endocrine gland—obesity	0.000167	0.00971	CbGeAlD
Nortriptyline—CYP3A5—islet of Langerhans—obesity	0.000154	0.00897	CbGeAlD
Nortriptyline—HTR1A—cardiovascular system—obesity	0.000152	0.00882	CbGeAlD
Nortriptyline—CYP1A2—respiratory system—obesity	0.000151	0.00878	CbGeAlD
Nortriptyline—CYP3A5—respiratory system—obesity	0.000146	0.00847	CbGeAlD
Nortriptyline—SLC6A4—digestive system—obesity	0.000142	0.00825	CbGeAlD
Nortriptyline—HRH1—respiratory system—obesity	0.000142	0.00822	CbGeAlD
Nortriptyline—ADRA1A—cardiovascular system—obesity	0.00014	0.00813	CbGeAlD
Nortriptyline—ALB—adrenal gland—obesity	0.000139	0.00809	CbGeAlD
Nortriptyline—ORM1—endocrine gland—obesity	0.000138	0.008	CbGeAlD
Nortriptyline—CYP2E1—respiratory system—obesity	0.000136	0.0079	CbGeAlD
Nortriptyline—CHRM3—adipose tissue—obesity	0.000134	0.00781	CbGeAlD
Nortriptyline—PTGS1—respiratory system—obesity	0.000131	0.00761	CbGeAlD
Nortriptyline—CHRM2—endocrine gland—obesity	0.000128	0.00746	CbGeAlD
Nortriptyline—CHRM3—digestive system—obesity	0.000127	0.00735	CbGeAlD
Nortriptyline—ORM1—liver—obesity	0.000124	0.00721	CbGeAlD
Nortriptyline—ADRA1A—adipose tissue—obesity	0.000123	0.00717	CbGeAlD
Nortriptyline—DRD2—pituitary gland—obesity	0.000122	0.00706	CbGeAlD
Nortriptyline—HTR1A—adrenal gland—obesity	0.00012	0.00698	CbGeAlD
Nortriptyline—SLC6A2—adrenal gland—obesity	0.000119	0.00692	CbGeAlD
Nortriptyline—HTR2A—respiratory system—obesity	0.000118	0.00686	CbGeAlD
Nortriptyline—CYP2C19—digestive system—obesity	0.000118	0.00683	CbGeAlD
Nortriptyline—SLC6A4—endocrine gland—obesity	0.000117	0.00682	CbGeAlD
Nortriptyline—CHRM1—endocrine gland—obesity	0.000117	0.00679	CbGeAlD
Nortriptyline—ADRA1A—adrenal gland—obesity	0.000111	0.00643	CbGeAlD
Nortriptyline—CYP2C9—cardiovascular system—obesity	0.00011	0.00638	CbGeAlD
Nortriptyline—ALB—liver—obesity	0.000109	0.00632	CbGeAlD
Nortriptyline—CHRM3—endocrine gland—obesity	0.000105	0.00608	CbGeAlD
Nortriptyline—HTR1A—endocrine gland—obesity	0.000104	0.00605	CbGeAlD
Nortriptyline—CYP2E1—cardiovascular system—obesity	0.000104	0.00605	CbGeAlD
Nortriptyline—SLC6A2—endocrine gland—obesity	0.000103	0.006	CbGeAlD
Nortriptyline—PTGS1—cardiovascular system—obesity	0.0001	0.00583	CbGeAlD
Nortriptyline—Amitriptyline—NTRK2—obesity	9.87e-05	0.0579	CrCbGaD
Nortriptyline—CYP3A5—adipose tissue—obesity	9.85e-05	0.00572	CbGeAlD
Nortriptyline—CYP2C19—endocrine gland—obesity	9.72e-05	0.00565	CbGeAlD
Nortriptyline—CYP1A2—digestive system—obesity	9.61e-05	0.00558	CbGeAlD
Nortriptyline—ADRA1A—endocrine gland—obesity	9.61e-05	0.00558	CbGeAlD
Nortriptyline—HRH1—adipose tissue—obesity	9.56e-05	0.00555	CbGeAlD
Nortriptyline—DRD2—endocrine gland—obesity	9.42e-05	0.00547	CbGeAlD
Nortriptyline—CYP3A5—digestive system—obesity	9.27e-05	0.00538	CbGeAlD
Nortriptyline—Body temperature increased—Cimetidine—obesity	9.15e-05	0.00141	CcSEcCtD
Nortriptyline—CYP2C9—digestive system—obesity	9.12e-05	0.0053	CbGeAlD
Nortriptyline—HTR2A—cardiovascular system—obesity	9.05e-05	0.00526	CbGeAlD
Nortriptyline—Pancytopenia—Bupropion—obesity	9e-05	0.00139	CcSEcCtD
Nortriptyline—HRH1—digestive system—obesity	9e-05	0.00523	CbGeAlD
Nortriptyline—Hepatitis—Orlistat—obesity	8.99e-05	0.00139	CcSEcCtD
Nortriptyline—Vomiting—Phentermine—obesity	8.89e-05	0.00137	CcSEcCtD
Nortriptyline—PTGS1—pituitary gland—obesity	8.88e-05	0.00516	CbGeAlD
Nortriptyline—Oedema peripheral—Orlistat—obesity	8.86e-05	0.00137	CcSEcCtD
Nortriptyline—PTGS1—adipose tissue—obesity	8.85e-05	0.00514	CbGeAlD
Nortriptyline—Rash—Phentermine—obesity	8.81e-05	0.00136	CcSEcCtD
Nortriptyline—Dermatitis—Phentermine—obesity	8.81e-05	0.00136	CcSEcCtD
Nortriptyline—CYP2C19—liver—obesity	8.77e-05	0.00509	CbGeAlD
Nortriptyline—Headache—Phentermine—obesity	8.76e-05	0.00135	CcSEcCtD
Nortriptyline—Pollakiuria—Bupropion—obesity	8.75e-05	0.00135	CcSEcCtD
Nortriptyline—Erectile dysfunction—Bupropion—obesity	8.73e-05	0.00135	CcSEcCtD
Nortriptyline—Nausea—Phenylpropanolamine—obesity	8.68e-05	0.00134	CcSEcCtD
Nortriptyline—ADRA1A—liver—obesity	8.66e-05	0.00503	CbGeAlD
Nortriptyline—Hypoaesthesia—Sibutramine—obesity	8.66e-05	0.00134	CcSEcCtD
Nortriptyline—CYP2E1—digestive system—obesity	8.65e-05	0.00502	CbGeAlD
Nortriptyline—Weight increased—Bupropion—obesity	8.62e-05	0.00133	CcSEcCtD
Nortriptyline—HRH1—adrenal gland—obesity	8.57e-05	0.00498	CbGeAlD
Nortriptyline—Weight decreased—Bupropion—obesity	8.57e-05	0.00132	CcSEcCtD
Nortriptyline—Oedema peripheral—Sibutramine—obesity	8.57e-05	0.00132	CcSEcCtD
Nortriptyline—Hypersensitivity—Cimetidine—obesity	8.52e-05	0.00132	CcSEcCtD
Nortriptyline—Acute coronary syndrome—Bupropion—obesity	8.33e-05	0.00129	CcSEcCtD
Nortriptyline—PTGS1—digestive system—obesity	8.33e-05	0.00484	CbGeAlD
Nortriptyline—Diarrhoea—Diethylpropion—obesity	8.32e-05	0.00129	CcSEcCtD
Nortriptyline—Nausea—Phentermine—obesity	8.3e-05	0.00128	CcSEcCtD
Nortriptyline—Asthenia—Cimetidine—obesity	8.3e-05	0.00128	CcSEcCtD
Nortriptyline—Myocardial infarction—Bupropion—obesity	8.28e-05	0.00128	CcSEcCtD
Nortriptyline—Neuropathy peripheral—Bupropion—obesity	8.28e-05	0.00128	CcSEcCtD
Nortriptyline—CYP2E1—adrenal gland—obesity	8.24e-05	0.00479	CbGeAlD
Nortriptyline—Jaundice—Bupropion—obesity	8.24e-05	0.00127	CcSEcCtD
Nortriptyline—Stomatitis—Bupropion—obesity	8.24e-05	0.00127	CcSEcCtD
Nortriptyline—Eye disorder—Sibutramine—obesity	8.13e-05	0.00126	CcSEcCtD
Nortriptyline—Tinnitus—Sibutramine—obesity	8.11e-05	0.00125	CcSEcCtD
Nortriptyline—Sweating—Bupropion—obesity	8.1e-05	0.00125	CcSEcCtD
Nortriptyline—Dizziness—Diethylpropion—obesity	8.04e-05	0.00124	CcSEcCtD
Nortriptyline—HTR2A—pituitary gland—obesity	8.02e-05	0.00466	CbGeAlD
Nortriptyline—Alopecia—Orlistat—obesity	7.94e-05	0.00123	CcSEcCtD
Nortriptyline—CYP1A2—endocrine gland—obesity	7.94e-05	0.00461	CbGeAlD
Nortriptyline—PTGS1—adrenal gland—obesity	7.94e-05	0.00461	CbGeAlD
Nortriptyline—Diarrhoea—Cimetidine—obesity	7.92e-05	0.00122	CcSEcCtD
Nortriptyline—Disorientation—Topiramate—obesity	7.81e-05	0.00121	CcSEcCtD
Nortriptyline—Vascular purpura—Topiramate—obesity	7.81e-05	0.00121	CcSEcCtD
Nortriptyline—Arrhythmia—Sibutramine—obesity	7.77e-05	0.0012	CcSEcCtD
Nortriptyline—Eye pain—Topiramate—obesity	7.74e-05	0.0012	CcSEcCtD
Nortriptyline—Vomiting—Diethylpropion—obesity	7.73e-05	0.00119	CcSEcCtD
Nortriptyline—Alopecia—Sibutramine—obesity	7.69e-05	0.00119	CcSEcCtD
Nortriptyline—Rash—Diethylpropion—obesity	7.67e-05	0.00118	CcSEcCtD
Nortriptyline—Dysgeusia—Orlistat—obesity	7.66e-05	0.00118	CcSEcCtD
Nortriptyline—CYP3A5—endocrine gland—obesity	7.66e-05	0.00445	CbGeAlD
Nortriptyline—Dermatitis—Diethylpropion—obesity	7.66e-05	0.00118	CcSEcCtD
Nortriptyline—Dizziness—Cimetidine—obesity	7.65e-05	0.00118	CcSEcCtD
Nortriptyline—Headache—Diethylpropion—obesity	7.62e-05	0.00118	CcSEcCtD
Nortriptyline—Hepatitis—Bupropion—obesity	7.59e-05	0.00117	CcSEcCtD
Nortriptyline—Hallucination—Bupropion—obesity	7.55e-05	0.00117	CcSEcCtD
Nortriptyline—Hypoaesthesia—Bupropion—obesity	7.55e-05	0.00117	CcSEcCtD
Nortriptyline—CYP2C9—endocrine gland—obesity	7.54e-05	0.00438	CbGeAlD
Nortriptyline—Libido decreased—Topiramate—obesity	7.53e-05	0.00116	CcSEcCtD
Nortriptyline—HTR2A—digestive system—obesity	7.52e-05	0.00436	CbGeAlD
Nortriptyline—Oedema peripheral—Bupropion—obesity	7.47e-05	0.00115	CcSEcCtD
Nortriptyline—Hot flush—Topiramate—obesity	7.47e-05	0.00115	CcSEcCtD
Nortriptyline—HRH1—endocrine gland—obesity	7.44e-05	0.00432	CbGeAlD
Nortriptyline—Tension—Sibutramine—obesity	7.43e-05	0.00115	CcSEcCtD
Nortriptyline—Dysgeusia—Sibutramine—obesity	7.42e-05	0.00115	CcSEcCtD
Nortriptyline—Menopausal symptoms—Topiramate—obesity	7.4e-05	0.00114	CcSEcCtD
Nortriptyline—Vision blurred—Orlistat—obesity	7.38e-05	0.00114	CcSEcCtD
Nortriptyline—Nervousness—Sibutramine—obesity	7.36e-05	0.00114	CcSEcCtD
Nortriptyline—Vomiting—Cimetidine—obesity	7.36e-05	0.00114	CcSEcCtD
Nortriptyline—Rash—Cimetidine—obesity	7.3e-05	0.00113	CcSEcCtD
Nortriptyline—Dermatitis—Cimetidine—obesity	7.29e-05	0.00113	CcSEcCtD
Nortriptyline—Ill-defined disorder—Orlistat—obesity	7.26e-05	0.00112	CcSEcCtD
Nortriptyline—Headache—Cimetidine—obesity	7.25e-05	0.00112	CcSEcCtD
Nortriptyline—Purpura—Topiramate—obesity	7.25e-05	0.00112	CcSEcCtD
Nortriptyline—Nausea—Diethylpropion—obesity	7.22e-05	0.00112	CcSEcCtD
Nortriptyline—HTR2A—adrenal gland—obesity	7.16e-05	0.00416	CbGeAlD
Nortriptyline—CYP1A2—liver—obesity	7.16e-05	0.00416	CbGeAlD
Nortriptyline—CYP2E1—endocrine gland—obesity	7.14e-05	0.00415	CbGeAlD
Nortriptyline—Vision blurred—Sibutramine—obesity	7.14e-05	0.0011	CcSEcCtD
Nortriptyline—Tremor—Sibutramine—obesity	7.1e-05	0.0011	CcSEcCtD
Nortriptyline—Eye disorder—Bupropion—obesity	7.09e-05	0.0011	CcSEcCtD
Nortriptyline—Tinnitus—Bupropion—obesity	7.07e-05	0.00109	CcSEcCtD
Nortriptyline—Malaise—Orlistat—obesity	7.06e-05	0.00109	CcSEcCtD
Nortriptyline—Flushing—Bupropion—obesity	7.04e-05	0.00109	CcSEcCtD
Nortriptyline—Ill-defined disorder—Sibutramine—obesity	7.03e-05	0.00109	CcSEcCtD
Nortriptyline—Agitation—Sibutramine—obesity	6.96e-05	0.00108	CcSEcCtD
Nortriptyline—CYP3A4—digestive system—obesity	6.96e-05	0.00404	CbGeAlD
Nortriptyline—Disturbance in sexual arousal—Topiramate—obesity	6.93e-05	0.00107	CcSEcCtD
Nortriptyline—Palpitations—Orlistat—obesity	6.92e-05	0.00107	CcSEcCtD
Nortriptyline—CYP3A5—liver—obesity	6.91e-05	0.00401	CbGeAlD
Nortriptyline—PTGS1—endocrine gland—obesity	6.88e-05	0.004	CbGeAlD
Nortriptyline—Nausea—Cimetidine—obesity	6.87e-05	0.00106	CcSEcCtD
Nortriptyline—CYP2D6—digestive system—obesity	6.85e-05	0.00398	CbGeAlD
Nortriptyline—Malaise—Sibutramine—obesity	6.83e-05	0.00106	CcSEcCtD
Nortriptyline—Psychotic disorder—Topiramate—obesity	6.82e-05	0.00105	CcSEcCtD
Nortriptyline—CYP2C9—liver—obesity	6.8e-05	0.00395	CbGeAlD
Nortriptyline—Syncope—Sibutramine—obesity	6.79e-05	0.00105	CcSEcCtD
Nortriptyline—Convulsion—Orlistat—obesity	6.78e-05	0.00105	CcSEcCtD
Nortriptyline—Leukopenia—Sibutramine—obesity	6.78e-05	0.00105	CcSEcCtD
Nortriptyline—Arrhythmia—Bupropion—obesity	6.78e-05	0.00105	CcSEcCtD
Nortriptyline—Alopecia—Bupropion—obesity	6.7e-05	0.00104	CcSEcCtD
Nortriptyline—Palpitations—Sibutramine—obesity	6.69e-05	0.00103	CcSEcCtD
Nortriptyline—Irritability—Topiramate—obesity	6.67e-05	0.00103	CcSEcCtD
Nortriptyline—Loss of consciousness—Sibutramine—obesity	6.66e-05	0.00103	CcSEcCtD
Nortriptyline—Urinary retention—Topiramate—obesity	6.64e-05	0.00103	CcSEcCtD
Nortriptyline—Anxiety—Orlistat—obesity	6.64e-05	0.00103	CcSEcCtD
Nortriptyline—Discomfort—Orlistat—obesity	6.58e-05	0.00102	CcSEcCtD
Nortriptyline—Ataxia—Topiramate—obesity	6.57e-05	0.00101	CcSEcCtD
Nortriptyline—Convulsion—Sibutramine—obesity	6.56e-05	0.00101	CcSEcCtD
Nortriptyline—Hypertension—Sibutramine—obesity	6.54e-05	0.00101	CcSEcCtD
Nortriptyline—Dry mouth—Orlistat—obesity	6.52e-05	0.00101	CcSEcCtD
Nortriptyline—Tension—Bupropion—obesity	6.48e-05	0.001	CcSEcCtD
Nortriptyline—Dysgeusia—Bupropion—obesity	6.47e-05	0.000999	CcSEcCtD
Nortriptyline—CYP2E1—liver—obesity	6.44e-05	0.00374	CbGeAlD
Nortriptyline—Anxiety—Sibutramine—obesity	6.43e-05	0.000993	CcSEcCtD
Nortriptyline—Nervousness—Bupropion—obesity	6.41e-05	0.000991	CcSEcCtD
Nortriptyline—Protriptyline—SLC6A4—obesity	6.41e-05	0.0375	CrCbGaD
Nortriptyline—Oedema—Orlistat—obesity	6.39e-05	0.000987	CcSEcCtD
Nortriptyline—Orthostatic hypotension—Topiramate—obesity	6.38e-05	0.000986	CcSEcCtD
Nortriptyline—Discomfort—Sibutramine—obesity	6.37e-05	0.000984	CcSEcCtD
Nortriptyline—Dry mouth—Sibutramine—obesity	6.31e-05	0.000975	CcSEcCtD
Nortriptyline—Confusional state—Sibutramine—obesity	6.23e-05	0.000963	CcSEcCtD
Nortriptyline—Vision blurred—Bupropion—obesity	6.22e-05	0.000962	CcSEcCtD
Nortriptyline—HTR2A—endocrine gland—obesity	6.21e-05	0.00361	CbGeAlD
Nortriptyline—Tremor—Bupropion—obesity	6.19e-05	0.000956	CcSEcCtD
Nortriptyline—Oedema—Sibutramine—obesity	6.18e-05	0.000955	CcSEcCtD
Nortriptyline—Hyperhidrosis—Orlistat—obesity	6.18e-05	0.000954	CcSEcCtD
Nortriptyline—Ill-defined disorder—Bupropion—obesity	6.13e-05	0.000947	CcSEcCtD
Nortriptyline—Shock—Sibutramine—obesity	6.08e-05	0.00094	CcSEcCtD
Nortriptyline—Agitation—Bupropion—obesity	6.07e-05	0.000938	CcSEcCtD
Nortriptyline—Thrombocytopenia—Sibutramine—obesity	6.05e-05	0.000935	CcSEcCtD
Nortriptyline—Tachycardia—Sibutramine—obesity	6.03e-05	0.000932	CcSEcCtD
Nortriptyline—Eosinophilia—Topiramate—obesity	5.98e-05	0.000924	CcSEcCtD
Nortriptyline—Hyperhidrosis—Sibutramine—obesity	5.98e-05	0.000923	CcSEcCtD
Nortriptyline—Malaise—Bupropion—obesity	5.95e-05	0.00092	CcSEcCtD
Nortriptyline—Syncope—Bupropion—obesity	5.92e-05	0.000915	CcSEcCtD
Nortriptyline—Leukopenia—Bupropion—obesity	5.91e-05	0.000913	CcSEcCtD
Nortriptyline—Anorexia—Sibutramine—obesity	5.89e-05	0.000911	CcSEcCtD
Nortriptyline—Sweating increased—Topiramate—obesity	5.88e-05	0.000909	CcSEcCtD
Nortriptyline—Palpitations—Bupropion—obesity	5.84e-05	0.000902	CcSEcCtD
Nortriptyline—Loss of consciousness—Bupropion—obesity	5.8e-05	0.000897	CcSEcCtD
Nortriptyline—Insomnia—Orlistat—obesity	5.78e-05	0.000893	CcSEcCtD
Nortriptyline—Hypotension—Sibutramine—obesity	5.78e-05	0.000893	CcSEcCtD
Nortriptyline—CYP3A4—endocrine gland—obesity	5.75e-05	0.00334	CbGeAlD
Nortriptyline—Paraesthesia—Orlistat—obesity	5.74e-05	0.000886	CcSEcCtD
Nortriptyline—Pancytopenia—Topiramate—obesity	5.73e-05	0.000886	CcSEcCtD
Nortriptyline—Convulsion—Bupropion—obesity	5.72e-05	0.000884	CcSEcCtD
Nortriptyline—Hypertension—Bupropion—obesity	5.7e-05	0.000881	CcSEcCtD
Nortriptyline—CYP2D6—endocrine gland—obesity	5.66e-05	0.00329	CbGeAlD
Nortriptyline—Dyspepsia—Orlistat—obesity	5.62e-05	0.000869	CcSEcCtD
Nortriptyline—Anxiety—Bupropion—obesity	5.6e-05	0.000866	CcSEcCtD
Nortriptyline—HTR2A—liver—obesity	5.6e-05	0.00325	CbGeAlD
Nortriptyline—Insomnia—Sibutramine—obesity	5.59e-05	0.000864	CcSEcCtD
Nortriptyline—Pollakiuria—Topiramate—obesity	5.58e-05	0.000862	CcSEcCtD
Nortriptyline—Erectile dysfunction—Topiramate—obesity	5.56e-05	0.000859	CcSEcCtD
Nortriptyline—Discomfort—Bupropion—obesity	5.55e-05	0.000858	CcSEcCtD
Nortriptyline—Decreased appetite—Orlistat—obesity	5.55e-05	0.000858	CcSEcCtD
Nortriptyline—Paraesthesia—Sibutramine—obesity	5.55e-05	0.000858	CcSEcCtD
Nortriptyline—Fatigue—Orlistat—obesity	5.51e-05	0.000851	CcSEcCtD
Nortriptyline—Dry mouth—Bupropion—obesity	5.5e-05	0.00085	CcSEcCtD
Nortriptyline—Somnolence—Sibutramine—obesity	5.5e-05	0.000849	CcSEcCtD
Nortriptyline—Weight increased—Topiramate—obesity	5.49e-05	0.000849	CcSEcCtD
Nortriptyline—Weight decreased—Topiramate—obesity	5.46e-05	0.000844	CcSEcCtD
Nortriptyline—Dyspepsia—Sibutramine—obesity	5.44e-05	0.000841	CcSEcCtD
Nortriptyline—Confusional state—Bupropion—obesity	5.43e-05	0.00084	CcSEcCtD
Nortriptyline—Oedema—Bupropion—obesity	5.39e-05	0.000833	CcSEcCtD
Nortriptyline—Decreased appetite—Sibutramine—obesity	5.37e-05	0.00083	CcSEcCtD
Nortriptyline—Shock—Bupropion—obesity	5.3e-05	0.000819	CcSEcCtD
Nortriptyline—Constipation—Sibutramine—obesity	5.29e-05	0.000817	CcSEcCtD
Nortriptyline—Neuropathy peripheral—Topiramate—obesity	5.28e-05	0.000815	CcSEcCtD
Nortriptyline—Thrombocytopenia—Bupropion—obesity	5.28e-05	0.000815	CcSEcCtD
Nortriptyline—Feeling abnormal—Orlistat—obesity	5.26e-05	0.000813	CcSEcCtD
Nortriptyline—Tachycardia—Bupropion—obesity	5.26e-05	0.000813	CcSEcCtD
Nortriptyline—Stomatitis—Topiramate—obesity	5.25e-05	0.000811	CcSEcCtD
Nortriptyline—Hyperhidrosis—Bupropion—obesity	5.21e-05	0.000805	CcSEcCtD
Nortriptyline—CYP3A4—liver—obesity	5.18e-05	0.00301	CbGeAlD
Nortriptyline—Anorexia—Bupropion—obesity	5.14e-05	0.000794	CcSEcCtD
Nortriptyline—CYP2D6—liver—obesity	5.1e-05	0.00296	CbGeAlD
Nortriptyline—Feeling abnormal—Sibutramine—obesity	5.09e-05	0.000787	CcSEcCtD
Nortriptyline—Urticaria—Orlistat—obesity	5.07e-05	0.000784	CcSEcCtD
Nortriptyline—Body temperature increased—Orlistat—obesity	5.05e-05	0.00078	CcSEcCtD
Nortriptyline—Abdominal pain—Orlistat—obesity	5.05e-05	0.00078	CcSEcCtD
Nortriptyline—Hypotension—Bupropion—obesity	5.04e-05	0.000778	CcSEcCtD
Nortriptyline—Agranulocytosis—Topiramate—obesity	5.02e-05	0.000776	CcSEcCtD
Nortriptyline—Maprotiline—HTR2C—obesity	4.93e-05	0.0289	CrCbGaD
Nortriptyline—Urticaria—Sibutramine—obesity	4.91e-05	0.000759	CcSEcCtD
Nortriptyline—Abdominal pain—Sibutramine—obesity	4.89e-05	0.000755	CcSEcCtD
Nortriptyline—Body temperature increased—Sibutramine—obesity	4.89e-05	0.000755	CcSEcCtD
Nortriptyline—Insomnia—Bupropion—obesity	4.87e-05	0.000753	CcSEcCtD
Nortriptyline—Paraesthesia—Bupropion—obesity	4.84e-05	0.000748	CcSEcCtD
Nortriptyline—Hepatitis—Topiramate—obesity	4.83e-05	0.000747	CcSEcCtD
Nortriptyline—Hypoaesthesia—Topiramate—obesity	4.81e-05	0.000743	CcSEcCtD
Nortriptyline—Hallucination—Topiramate—obesity	4.81e-05	0.000743	CcSEcCtD
Nortriptyline—Somnolence—Bupropion—obesity	4.79e-05	0.00074	CcSEcCtD
Nortriptyline—Oedema peripheral—Topiramate—obesity	4.76e-05	0.000736	CcSEcCtD
Nortriptyline—Dyspepsia—Bupropion—obesity	4.74e-05	0.000733	CcSEcCtD
Nortriptyline—Hypersensitivity—Orlistat—obesity	4.71e-05	0.000727	CcSEcCtD
Nortriptyline—Decreased appetite—Bupropion—obesity	4.68e-05	0.000724	CcSEcCtD
Nortriptyline—Fatigue—Bupropion—obesity	4.65e-05	0.000718	CcSEcCtD
Nortriptyline—Constipation—Bupropion—obesity	4.61e-05	0.000712	CcSEcCtD
Nortriptyline—Asthenia—Orlistat—obesity	4.58e-05	0.000708	CcSEcCtD
Nortriptyline—Hypersensitivity—Sibutramine—obesity	4.55e-05	0.000704	CcSEcCtD
Nortriptyline—Pruritus—Orlistat—obesity	4.52e-05	0.000698	CcSEcCtD
Nortriptyline—Eye disorder—Topiramate—obesity	4.52e-05	0.000698	CcSEcCtD
Nortriptyline—Tinnitus—Topiramate—obesity	4.51e-05	0.000696	CcSEcCtD
Nortriptyline—Flushing—Topiramate—obesity	4.49e-05	0.000693	CcSEcCtD
Nortriptyline—Feeling abnormal—Bupropion—obesity	4.44e-05	0.000686	CcSEcCtD
Nortriptyline—Asthenia—Sibutramine—obesity	4.44e-05	0.000685	CcSEcCtD
Nortriptyline—Pruritus—Sibutramine—obesity	4.37e-05	0.000676	CcSEcCtD
Nortriptyline—Cyproheptadine—HTR2C—obesity	4.37e-05	0.0256	CrCbGaD
Nortriptyline—Diarrhoea—Orlistat—obesity	4.37e-05	0.000675	CcSEcCtD
Nortriptyline—Urticaria—Bupropion—obesity	4.28e-05	0.000662	CcSEcCtD
Nortriptyline—Alopecia—Topiramate—obesity	4.27e-05	0.00066	CcSEcCtD
Nortriptyline—Abdominal pain—Bupropion—obesity	4.26e-05	0.000658	CcSEcCtD
Nortriptyline—Body temperature increased—Bupropion—obesity	4.26e-05	0.000658	CcSEcCtD
Nortriptyline—Diarrhoea—Sibutramine—obesity	4.23e-05	0.000654	CcSEcCtD
Nortriptyline—Dizziness—Orlistat—obesity	4.22e-05	0.000653	CcSEcCtD
Nortriptyline—Atomoxetine—HTR1B—obesity	4.16e-05	0.0244	CrCbGaD
Nortriptyline—Tension—Topiramate—obesity	4.13e-05	0.000638	CcSEcCtD
Nortriptyline—Dysgeusia—Topiramate—obesity	4.12e-05	0.000637	CcSEcCtD
Nortriptyline—Dizziness—Sibutramine—obesity	4.09e-05	0.000632	CcSEcCtD
Nortriptyline—Nervousness—Topiramate—obesity	4.09e-05	0.000631	CcSEcCtD
Nortriptyline—Maprotiline—DRD2—obesity	4.06e-05	0.0238	CrCbGaD
Nortriptyline—Vomiting—Orlistat—obesity	4.06e-05	0.000628	CcSEcCtD
Nortriptyline—Rash—Orlistat—obesity	4.03e-05	0.000622	CcSEcCtD
Nortriptyline—Dermatitis—Orlistat—obesity	4.02e-05	0.000622	CcSEcCtD
Nortriptyline—Headache—Orlistat—obesity	4e-05	0.000618	CcSEcCtD
Nortriptyline—Hypersensitivity—Bupropion—obesity	3.97e-05	0.000614	CcSEcCtD
Nortriptyline—Vision blurred—Topiramate—obesity	3.96e-05	0.000613	CcSEcCtD
Nortriptyline—Tremor—Topiramate—obesity	3.94e-05	0.000609	CcSEcCtD
Nortriptyline—Vomiting—Sibutramine—obesity	3.93e-05	0.000607	CcSEcCtD
Nortriptyline—Ill-defined disorder—Topiramate—obesity	3.9e-05	0.000603	CcSEcCtD
Nortriptyline—Rash—Sibutramine—obesity	3.9e-05	0.000602	CcSEcCtD
Nortriptyline—Dermatitis—Sibutramine—obesity	3.89e-05	0.000602	CcSEcCtD
Nortriptyline—Headache—Sibutramine—obesity	3.87e-05	0.000598	CcSEcCtD
Nortriptyline—Asthenia—Bupropion—obesity	3.87e-05	0.000597	CcSEcCtD
Nortriptyline—Agitation—Topiramate—obesity	3.87e-05	0.000597	CcSEcCtD
Nortriptyline—Pruritus—Bupropion—obesity	3.81e-05	0.000589	CcSEcCtD
Nortriptyline—Nausea—Orlistat—obesity	3.79e-05	0.000586	CcSEcCtD
Nortriptyline—Malaise—Topiramate—obesity	3.79e-05	0.000586	CcSEcCtD
Nortriptyline—Syncope—Topiramate—obesity	3.77e-05	0.000583	CcSEcCtD
Nortriptyline—Leukopenia—Topiramate—obesity	3.77e-05	0.000582	CcSEcCtD
Nortriptyline—Palpitations—Topiramate—obesity	3.72e-05	0.000574	CcSEcCtD
Nortriptyline—Loss of consciousness—Topiramate—obesity	3.7e-05	0.000571	CcSEcCtD
Nortriptyline—Diarrhoea—Bupropion—obesity	3.69e-05	0.00057	CcSEcCtD
Nortriptyline—Cyclobenzaprine—HTR2A—obesity	3.67e-05	0.0215	CrCbGaD
Nortriptyline—Nausea—Sibutramine—obesity	3.67e-05	0.000567	CcSEcCtD
Nortriptyline—Epinastine—HTR2A—obesity	3.65e-05	0.0214	CrCbGaD
Nortriptyline—Convulsion—Topiramate—obesity	3.65e-05	0.000563	CcSEcCtD
Nortriptyline—Hypertension—Topiramate—obesity	3.63e-05	0.000561	CcSEcCtD
Nortriptyline—Cyproheptadine—DRD2—obesity	3.6e-05	0.0211	CrCbGaD
Nortriptyline—Anxiety—Topiramate—obesity	3.57e-05	0.000552	CcSEcCtD
Nortriptyline—Dizziness—Bupropion—obesity	3.56e-05	0.000551	CcSEcCtD
Nortriptyline—Discomfort—Topiramate—obesity	3.54e-05	0.000547	CcSEcCtD
Nortriptyline—Chlorprothixene—DRD1—obesity	3.53e-05	0.0207	CrCbGaD
Nortriptyline—Dry mouth—Topiramate—obesity	3.5e-05	0.000541	CcSEcCtD
Nortriptyline—Desipramine—SLC22A1—obesity	3.49e-05	0.0204	CrCbGaD
Nortriptyline—Confusional state—Topiramate—obesity	3.46e-05	0.000535	CcSEcCtD
Nortriptyline—Oedema—Topiramate—obesity	3.43e-05	0.000531	CcSEcCtD
Nortriptyline—Vomiting—Bupropion—obesity	3.43e-05	0.000529	CcSEcCtD
Nortriptyline—Rash—Bupropion—obesity	3.4e-05	0.000525	CcSEcCtD
Nortriptyline—Dermatitis—Bupropion—obesity	3.39e-05	0.000525	CcSEcCtD
Nortriptyline—Atomoxetine—HTR2C—obesity	3.39e-05	0.0199	CrCbGaD
Nortriptyline—Shock—Topiramate—obesity	3.38e-05	0.000522	CcSEcCtD
Nortriptyline—Headache—Bupropion—obesity	3.38e-05	0.000522	CcSEcCtD
Nortriptyline—Thrombocytopenia—Topiramate—obesity	3.36e-05	0.000519	CcSEcCtD
Nortriptyline—Tachycardia—Topiramate—obesity	3.35e-05	0.000518	CcSEcCtD
Nortriptyline—Hyperhidrosis—Topiramate—obesity	3.32e-05	0.000513	CcSEcCtD
Nortriptyline—Mianserin—HTR2C—obesity	3.31e-05	0.0194	CrCbGaD
Nortriptyline—Anorexia—Topiramate—obesity	3.27e-05	0.000506	CcSEcCtD
Nortriptyline—Hypotension—Topiramate—obesity	3.21e-05	0.000496	CcSEcCtD
Nortriptyline—Nausea—Bupropion—obesity	3.2e-05	0.000495	CcSEcCtD
Nortriptyline—Maprotiline—HTR2A—obesity	3.14e-05	0.0184	CrCbGaD
Nortriptyline—Insomnia—Topiramate—obesity	3.11e-05	0.00048	CcSEcCtD
Nortriptyline—Paraesthesia—Topiramate—obesity	3.08e-05	0.000476	CcSEcCtD
Nortriptyline—Somnolence—Topiramate—obesity	3.05e-05	0.000472	CcSEcCtD
Nortriptyline—Clomipramine—HTR2C—obesity	3.03e-05	0.0178	CrCbGaD
Nortriptyline—Dyspepsia—Topiramate—obesity	3.02e-05	0.000467	CcSEcCtD
Nortriptyline—Chlorprothixene—HTR2C—obesity	3.02e-05	0.0177	CrCbGaD
Nortriptyline—Decreased appetite—Topiramate—obesity	2.98e-05	0.000461	CcSEcCtD
Nortriptyline—Fatigue—Topiramate—obesity	2.96e-05	0.000457	CcSEcCtD
Nortriptyline—Imipramine—SLC22A1—obesity	2.96e-05	0.0173	CrCbGaD
Nortriptyline—Constipation—Topiramate—obesity	2.94e-05	0.000454	CcSEcCtD
Nortriptyline—Feeling abnormal—Topiramate—obesity	2.83e-05	0.000437	CcSEcCtD
Nortriptyline—Atomoxetine—SLC6A4—obesity	2.81e-05	0.0165	CrCbGaD
Nortriptyline—Trimipramine—HTR2C—obesity	2.79e-05	0.0163	CrCbGaD
Nortriptyline—Cyproheptadine—HTR2A—obesity	2.78e-05	0.0163	CrCbGaD
Nortriptyline—Mianserin—SLC6A4—obesity	2.75e-05	0.0161	CrCbGaD
Nortriptyline—Mianserin—DRD2—obesity	2.73e-05	0.016	CrCbGaD
Nortriptyline—Urticaria—Topiramate—obesity	2.73e-05	0.000421	CcSEcCtD
Nortriptyline—Body temperature increased—Topiramate—obesity	2.71e-05	0.000419	CcSEcCtD
Nortriptyline—Abdominal pain—Topiramate—obesity	2.71e-05	0.000419	CcSEcCtD
Nortriptyline—Doxepin—HTR2C—obesity	2.66e-05	0.0156	CrCbGaD
Nortriptyline—Desipramine—ADRB1—obesity	2.65e-05	0.0155	CrCbGaD
Nortriptyline—Hypersensitivity—Topiramate—obesity	2.53e-05	0.000391	CcSEcCtD
Nortriptyline—Amitriptyline—HTR1B—obesity	2.52e-05	0.0148	CrCbGaD
Nortriptyline—Clomipramine—SLC6A4—obesity	2.51e-05	0.0147	CrCbGaD
Nortriptyline—Chlorprothixene—DRD2—obesity	2.49e-05	0.0146	CrCbGaD
Nortriptyline—Asthenia—Topiramate—obesity	2.46e-05	0.000381	CcSEcCtD
Nortriptyline—Desipramine—HTR2C—obesity	2.44e-05	0.0143	CrCbGaD
Nortriptyline—Pruritus—Topiramate—obesity	2.43e-05	0.000375	CcSEcCtD
Nortriptyline—Diarrhoea—Topiramate—obesity	2.35e-05	0.000363	CcSEcCtD
Nortriptyline—Trimipramine—SLC6A4—obesity	2.31e-05	0.0135	CrCbGaD
Nortriptyline—Oxcarbazepine—ALB—obesity	2.3e-05	0.0135	CrCbGaD
Nortriptyline—Trimipramine—DRD2—obesity	2.3e-05	0.0135	CrCbGaD
Nortriptyline—Dizziness—Topiramate—obesity	2.27e-05	0.000351	CcSEcCtD
Nortriptyline—Desipramine—ADRB2—obesity	2.23e-05	0.013	CrCbGaD
Nortriptyline—Doxepin—SLC6A4—obesity	2.2e-05	0.0129	CrCbGaD
Nortriptyline—Doxepin—DRD2—obesity	2.19e-05	0.0128	CrCbGaD
Nortriptyline—Vomiting—Topiramate—obesity	2.18e-05	0.000337	CcSEcCtD
Nortriptyline—Rash—Topiramate—obesity	2.16e-05	0.000335	CcSEcCtD
Nortriptyline—Dermatitis—Topiramate—obesity	2.16e-05	0.000334	CcSEcCtD
Nortriptyline—Atomoxetine—HTR2A—obesity	2.16e-05	0.0127	CrCbGaD
Nortriptyline—Headache—Topiramate—obesity	2.15e-05	0.000332	CcSEcCtD
Nortriptyline—Mianserin—HTR2A—obesity	2.11e-05	0.0124	CrCbGaD
Nortriptyline—Imipramine—HTR2C—obesity	2.07e-05	0.0121	CrCbGaD
Nortriptyline—Amitriptyline—HTR2C—obesity	2.06e-05	0.012	CrCbGaD
Nortriptyline—Nausea—Topiramate—obesity	2.04e-05	0.000315	CcSEcCtD
Nortriptyline—Desipramine—SLC6A4—obesity	2.02e-05	0.0118	CrCbGaD
Nortriptyline—Desipramine—DRD2—obesity	2.01e-05	0.0118	CrCbGaD
Nortriptyline—Desipramine—CYP2E1—obesity	1.93e-05	0.0113	CrCbGaD
Nortriptyline—Clomipramine—HTR2A—obesity	1.93e-05	0.0113	CrCbGaD
Nortriptyline—Chlorprothixene—HTR2A—obesity	1.92e-05	0.0113	CrCbGaD
Nortriptyline—Trimipramine—HTR2A—obesity	1.78e-05	0.0104	CrCbGaD
Nortriptyline—Imipramine—SLC6A4—obesity	1.71e-05	0.01	CrCbGaD
Nortriptyline—Imipramine—DRD2—obesity	1.7e-05	0.00999	CrCbGaD
Nortriptyline—Amitriptyline—SLC6A4—obesity	1.7e-05	0.00998	CrCbGaD
Nortriptyline—Amitriptyline—DRD2—obesity	1.69e-05	0.00993	CrCbGaD
Nortriptyline—Doxepin—HTR2A—obesity	1.69e-05	0.00992	CrCbGaD
Nortriptyline—Imipramine—CYP2E1—obesity	1.64e-05	0.00962	CrCbGaD
Nortriptyline—Amitriptyline—CYP2E1—obesity	1.63e-05	0.00956	CrCbGaD
Nortriptyline—Desipramine—HTR2A—obesity	1.55e-05	0.0091	CrCbGaD
Nortriptyline—Clomipramine—ALB—obesity	1.32e-05	0.00774	CrCbGaD
Nortriptyline—Imipramine—HTR2A—obesity	1.32e-05	0.00772	CrCbGaD
Nortriptyline—Amitriptyline—HTR2A—obesity	1.31e-05	0.00767	CrCbGaD
Nortriptyline—Amitriptyline—ALB—obesity	8.96e-06	0.00525	CrCbGaD
Nortriptyline—DRD2—Signaling Pathways—MTOR—obesity	4.75e-07	8.29e-06	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—CAV1—obesity	4.75e-07	8.28e-06	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—MYC—obesity	4.74e-07	8.27e-06	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—APOA1—obesity	4.74e-07	8.26e-06	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—PIK3CA—obesity	4.73e-07	8.26e-06	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—TGFB1—obesity	4.73e-07	8.25e-06	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—GPX1—obesity	4.72e-07	8.24e-06	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—PIK3CA—obesity	4.72e-07	8.24e-06	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—IL6—obesity	4.71e-07	8.21e-06	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—CAV1—obesity	4.7e-07	8.21e-06	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—MMP9—obesity	4.7e-07	8.2e-06	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PIK3CG—obesity	4.7e-07	8.2e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CYCS—obesity	4.7e-07	8.2e-06	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—APOA1—obesity	4.69e-07	8.19e-06	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—MMP9—obesity	4.68e-07	8.16e-06	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—MTOR—obesity	4.67e-07	8.15e-06	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—PIK3CB—obesity	4.67e-07	8.15e-06	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—PIK3CB—obesity	4.67e-07	8.15e-06	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—MTOR—obesity	4.66e-07	8.14e-06	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—PIK3CB—obesity	4.66e-07	8.14e-06	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—PIK3CB—obesity	4.66e-07	8.13e-06	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—PIK3CB—obesity	4.65e-07	8.11e-06	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—MTOR—obesity	4.65e-07	8.11e-06	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—MTOR—obesity	4.63e-07	8.08e-06	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—PIK3CB—obesity	4.63e-07	8.08e-06	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—PTGS2—obesity	4.63e-07	8.07e-06	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—PTGS2—obesity	4.62e-07	8.06e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—GOT1—obesity	4.61e-07	8.05e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—GGT1—obesity	4.61e-07	8.05e-06	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PIK3CD—obesity	4.6e-07	8.03e-06	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—CD36—obesity	4.6e-07	8.03e-06	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—MTOR—obesity	4.59e-07	8.01e-06	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—PIK3CB—obesity	4.59e-07	8.01e-06	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—MTOR—obesity	4.57e-07	7.98e-06	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—PIK3CB—obesity	4.57e-07	7.98e-06	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—MAPK8—obesity	4.57e-07	7.98e-06	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—AKT1—obesity	4.56e-07	7.96e-06	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—MAPK8—obesity	4.55e-07	7.94e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—NCOA1—obesity	4.54e-07	7.93e-06	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PPARG—obesity	4.54e-07	7.92e-06	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—AKT1—obesity	4.54e-07	7.92e-06	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—obesity	4.49e-07	7.84e-06	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—MMP9—obesity	4.48e-07	7.81e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—STK11—obesity	4.48e-07	7.81e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CYP19A1—obesity	4.48e-07	7.81e-06	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—POMC—obesity	4.47e-07	7.81e-06	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—MYC—obesity	4.46e-07	7.78e-06	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—PIK3CA—obesity	4.45e-07	7.77e-06	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—INS—obesity	4.45e-07	7.76e-06	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—TGFB1—obesity	4.45e-07	7.76e-06	CbGpPWpGaD
Nortriptyline—DRD2—GPCR downstream signaling—AKT1—obesity	4.41e-07	7.69e-06	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—MTHFR—obesity	4.36e-07	7.61e-06	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—MAPK8—obesity	4.35e-07	7.6e-06	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—NOS3—obesity	4.35e-07	7.59e-06	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PIK3R1—obesity	4.35e-07	7.59e-06	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—AKT1—obesity	4.34e-07	7.58e-06	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—IL6—obesity	4.34e-07	7.57e-06	CbGpPWpGaD
Nortriptyline—HTR2A—GPCR downstream signaling—AKT1—obesity	4.34e-07	7.57e-06	CbGpPWpGaD
Nortriptyline—HRH1—GPCR downstream signaling—AKT1—obesity	4.33e-07	7.55e-06	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PIK3CG—obesity	4.32e-07	7.54e-06	CbGpPWpGaD
Nortriptyline—CHRM1—GPCR downstream signaling—AKT1—obesity	4.31e-07	7.53e-06	CbGpPWpGaD
Nortriptyline—CHRM3—GPCR downstream signaling—AKT1—obesity	4.3e-07	7.5e-06	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PIK3CG—obesity	4.29e-07	7.48e-06	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PPARA—obesity	4.28e-07	7.46e-06	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—IL6—obesity	4.27e-07	7.45e-06	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—IL6—obesity	4.26e-07	7.43e-06	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR downstream signaling—AKT1—obesity	4.26e-07	7.43e-06	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR downstream signaling—AKT1—obesity	4.25e-07	7.41e-06	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—IL6—obesity	4.25e-07	7.41e-06	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—IL6—obesity	4.23e-07	7.39e-06	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—PIK3CA—obesity	4.2e-07	7.33e-06	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—IL6—obesity	4.19e-07	7.32e-06	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—IL6—obesity	4.18e-07	7.3e-06	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—STAT3—obesity	4.18e-07	7.29e-06	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PPARG—obesity	4.17e-07	7.28e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—COMT—obesity	4.16e-07	7.26e-06	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—STAT3—obesity	4.16e-07	7.26e-06	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—AGT—obesity	4.14e-07	7.23e-06	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PPARG—obesity	4.14e-07	7.22e-06	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PIK3CD—obesity	4.13e-07	7.21e-06	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—MMP9—obesity	4.13e-07	7.2e-06	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—POMC—obesity	4.11e-07	7.18e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—GNB3—obesity	4.1e-07	7.16e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PPARGC1A—obesity	4.1e-07	7.16e-06	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—INS—obesity	4.09e-07	7.14e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—HMOX1—obesity	4.08e-07	7.13e-06	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—POMC—obesity	4.08e-07	7.12e-06	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—ALB—obesity	4.08e-07	7.12e-06	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—MMP9—obesity	4.06e-07	7.09e-06	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—APOE—obesity	4.06e-07	7.08e-06	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—INS—obesity	4.06e-07	7.08e-06	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—MMP9—obesity	4.05e-07	7.07e-06	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—MMP9—obesity	4.04e-07	7.05e-06	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—MMP9—obesity	4.03e-07	7.03e-06	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—PIK3CA—obesity	4.02e-07	7.02e-06	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—CAV1—obesity	4.02e-07	7.02e-06	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—MAPK8—obesity	4.01e-07	7.01e-06	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PIK3CB—obesity	4.01e-07	7e-06	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—APOA1—obesity	4.01e-07	7e-06	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—AKT1—obesity	4e-07	6.99e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—GNAS—obesity	4e-07	6.97e-06	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—MMP9—obesity	3.99e-07	6.96e-06	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—STAT3—obesity	3.98e-07	6.95e-06	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—MMP9—obesity	3.98e-07	6.94e-06	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PTGS2—obesity	3.98e-07	6.94e-06	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—MAPK8—obesity	3.95e-07	6.89e-06	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—IL6—obesity	3.94e-07	6.88e-06	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—MAPK8—obesity	3.94e-07	6.88e-06	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—AKT1—obesity	3.94e-07	6.87e-06	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—AKT1—obesity	3.93e-07	6.86e-06	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—MAPK8—obesity	3.93e-07	6.86e-06	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—AKT1—obesity	3.92e-07	6.84e-06	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—MAPK8—obesity	3.92e-07	6.83e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—APOB—obesity	3.91e-07	6.83e-06	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—AKT1—obesity	3.91e-07	6.82e-06	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PIK3R1—obesity	3.9e-07	6.81e-06	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—NOS3—obesity	3.9e-07	6.81e-06	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—MYC—obesity	3.88e-07	6.78e-06	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—MAPK8—obesity	3.88e-07	6.77e-06	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—TGFB1—obesity	3.87e-07	6.76e-06	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—AKT1—obesity	3.87e-07	6.75e-06	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—MAPK8—obesity	3.87e-07	6.75e-06	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—MYC—obesity	3.86e-07	6.74e-06	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—AKT1—obesity	3.86e-07	6.73e-06	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—TGFB1—obesity	3.85e-07	6.73e-06	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	3.84e-07	6.7e-06	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—PIK3CA—obesity	3.81e-07	6.65e-06	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PIK3CD—obesity	3.8e-07	6.63e-06	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—PIK3CA—obesity	3.78e-07	6.6e-06	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PIK3CD—obesity	3.77e-07	6.58e-06	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—ALB—obesity	3.75e-07	6.55e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—LPL—obesity	3.74e-07	6.52e-06	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—IL6—obesity	3.72e-07	6.49e-06	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—ALB—obesity	3.72e-07	6.49e-06	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—MYC—obesity	3.7e-07	6.45e-06	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—TGFB1—obesity	3.69e-07	6.44e-06	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—STAT3—obesity	3.67e-07	6.4e-06	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PIK3CG—obesity	3.66e-07	6.39e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—GPX1—obesity	3.65e-07	6.36e-06	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—AKT1—obesity	3.64e-07	6.35e-06	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—STAT3—obesity	3.61e-07	6.3e-06	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—STAT3—obesity	3.6e-07	6.29e-06	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PIK3CB—obesity	3.6e-07	6.29e-06	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—STAT3—obesity	3.59e-07	6.27e-06	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PIK3R1—obesity	3.59e-07	6.26e-06	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—NOS3—obesity	3.59e-07	6.26e-06	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—STAT3—obesity	3.58e-07	6.25e-06	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PTGS2—obesity	3.57e-07	6.23e-06	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—IL6—obesity	3.56e-07	6.22e-06	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—NOS3—obesity	3.56e-07	6.21e-06	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PIK3R1—obesity	3.56e-07	6.21e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CD36—obesity	3.55e-07	6.2e-06	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—STAT3—obesity	3.55e-07	6.19e-06	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—STAT3—obesity	3.54e-07	6.17e-06	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PPARG—obesity	3.53e-07	6.17e-06	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—POMC—obesity	3.49e-07	6.08e-06	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—INS—obesity	3.47e-07	6.05e-06	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—AKT1—obesity	3.43e-07	5.99e-06	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—MYC—obesity	3.41e-07	5.95e-06	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—TGFB1—obesity	3.4e-07	5.94e-06	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—PIK3CA—obesity	3.38e-07	5.89e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—MTHFR—obesity	3.36e-07	5.87e-06	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—MYC—obesity	3.36e-07	5.86e-06	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—IL6—obesity	3.35e-07	5.85e-06	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—MYC—obesity	3.35e-07	5.84e-06	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—TGFB1—obesity	3.35e-07	5.84e-06	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—TGFB1—obesity	3.34e-07	5.83e-06	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—MYC—obesity	3.34e-07	5.82e-06	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—TGFB1—obesity	3.33e-07	5.81e-06	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—MYC—obesity	3.33e-07	5.81e-06	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—TGFB1—obesity	3.32e-07	5.79e-06	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PIK3CB—obesity	3.31e-07	5.78e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PPARA—obesity	3.3e-07	5.76e-06	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—PIK3CA—obesity	3.3e-07	5.75e-06	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—MYC—obesity	3.29e-07	5.75e-06	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—AKT1—obesity	3.29e-07	5.74e-06	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—TGFB1—obesity	3.29e-07	5.74e-06	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—MYC—obesity	3.29e-07	5.73e-06	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PIK3CB—obesity	3.28e-07	5.73e-06	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PTGS2—obesity	3.28e-07	5.73e-06	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—PIK3CA—obesity	3.28e-07	5.72e-06	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—TGFB1—obesity	3.28e-07	5.72e-06	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PTGS2—obesity	3.25e-07	5.68e-06	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PIK3CD—obesity	3.22e-07	5.62e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—AGT—obesity	3.2e-07	5.58e-06	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—ALB—obesity	3.18e-07	5.55e-06	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—PIK3CA—obesity	3.14e-07	5.48e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—APOE—obesity	3.13e-07	5.47e-06	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—AKT1—obesity	3.11e-07	5.43e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CAV1—obesity	3.1e-07	5.42e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—APOA1—obesity	3.1e-07	5.4e-06	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—AKT1—obesity	3.09e-07	5.39e-06	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PIK3R1—obesity	3.04e-07	5.31e-06	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—NOS3—obesity	3.04e-07	5.31e-06	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—IL6—obesity	2.92e-07	5.09e-06	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—IL6—obesity	2.9e-07	5.07e-06	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—PIK3CA—obesity	2.89e-07	5.05e-06	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—PIK3CA—obesity	2.85e-07	4.97e-06	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—PIK3CA—obesity	2.85e-07	4.97e-06	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—PIK3CA—obesity	2.84e-07	4.96e-06	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—PIK3CA—obesity	2.84e-07	4.96e-06	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—PIK3CA—obesity	2.83e-07	4.94e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PIK3CG—obesity	2.83e-07	4.93e-06	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—PIK3CA—obesity	2.82e-07	4.93e-06	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PIK3CB—obesity	2.81e-07	4.9e-06	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—PIK3CA—obesity	2.8e-07	4.88e-06	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—PIK3CA—obesity	2.79e-07	4.87e-06	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PTGS2—obesity	2.78e-07	4.85e-06	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—IL6—obesity	2.78e-07	4.85e-06	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—AKT1—obesity	2.76e-07	4.81e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PPARG—obesity	2.73e-07	4.76e-06	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—AKT1—obesity	2.69e-07	4.7e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—POMC—obesity	2.69e-07	4.7e-06	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—AKT1—obesity	2.68e-07	4.68e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—INS—obesity	2.68e-07	4.67e-06	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—AKT1—obesity	2.56e-07	4.48e-06	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—IL6—obesity	2.56e-07	4.47e-06	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—IL6—obesity	2.52e-07	4.4e-06	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—IL6—obesity	2.52e-07	4.39e-06	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—IL6—obesity	2.51e-07	4.38e-06	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—IL6—obesity	2.5e-07	4.36e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PIK3CD—obesity	2.48e-07	4.34e-06	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—IL6—obesity	2.48e-07	4.32e-06	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—IL6—obesity	2.47e-07	4.31e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—ALB—obesity	2.45e-07	4.28e-06	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PIK3CA—obesity	2.45e-07	4.27e-06	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—AKT1—obesity	2.36e-07	4.13e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PIK3R1—obesity	2.35e-07	4.09e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—NOS3—obesity	2.35e-07	4.09e-06	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—AKT1—obesity	2.33e-07	4.06e-06	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—AKT1—obesity	2.32e-07	4.06e-06	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—AKT1—obesity	2.32e-07	4.05e-06	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—AKT1—obesity	2.32e-07	4.05e-06	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—AKT1—obesity	2.31e-07	4.04e-06	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—AKT1—obesity	2.31e-07	4.03e-06	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—AKT1—obesity	2.28e-07	3.99e-06	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—AKT1—obesity	2.28e-07	3.98e-06	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PIK3CA—obesity	2.2e-07	3.83e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PIK3CB—obesity	2.17e-07	3.78e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PTGS2—obesity	2.15e-07	3.75e-06	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PIK3CA—obesity	2.02e-07	3.52e-06	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PIK3CA—obesity	2e-07	3.49e-06	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—AKT1—obesity	2e-07	3.49e-06	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—AKT1—obesity	1.79e-07	3.13e-06	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PIK3CA—obesity	1.71e-07	2.99e-06	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—AKT1—obesity	1.65e-07	2.88e-06	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—AKT1—obesity	1.64e-07	2.85e-06	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—AKT1—obesity	1.4e-07	2.44e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PIK3CA—obesity	1.32e-07	2.3e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—AKT1—obesity	1.08e-07	1.88e-06	CbGpPWpGaD
